-
Arnold K, Bordoli L, Kopp J, Schwede T, 2006: The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling[J]. Bioinformatics, 22, 195-201. doi: 10.1093/bioinformatics/bti770
-
Baker D, Sali A, 2001: Protein structure prediction and structural genomics[J]. Science, 294, 93-96. doi: 10.1126/science.1065659
-
Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC, 2002: Compromised influenza virus-specific CD8+-T-cell memory in CD4+-T-cell-deficient mice[J]. J Virol, 76, 12388-12393. doi: 10.1128/JVI.76.23.12388-12393.2002
-
Benkert P, Tosatto SC, Schomburg D, 2008: QMEAN: A comprehensive scoring function for model quality assessment[J]. Proteins, 71, 261-277. doi: 10.1002/prot.v71:1
-
Ben-Yedidia T, Arnon R, 2007: Epitope-based vaccine against influenza[J]. Expert Rev Vaccines, 6, 39-48.
-
Bot A, Antohi S, Bot S, Garcia-Sastre A, Bona C, 1997: Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene[J]. Int Immunol, 9, 1641-1650. doi: 10.1093/intimm/9.11.1641
-
Chen X, Zhang W, Gao W, Zou Q, Feng C, Liu H, Zhou C, Zhang Y, Wang B, 2012: Hemokinin-1 as an adjuvant molecule enhancing humoral and memory responses to HBsAg DNA vaccination[J]. Viral Immunol, 25, 289-296. doi: 10.1089/vim.2012.0015
-
Cheung YK, Cheng SC.-S, Ke Y, Xie Y, 2010: Two novel HLA-A* 0201 T-cell epitopes in avian H5N1 viral nucleoprotein induced specific immune responses in HHD mice[J]. Vet Res, 41, 24-. doi: 10.1051/vetres/2009071
-
Danke NA, Kwok WW, 2003: HLA class Ⅱ-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination[J]. J Immunol, 171, 3163-3169. doi: 10.4049/jimmunol.171.6.3163
-
Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, Xu L, Nabel GJ, 2005: Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein[J]. Vaccine, 23, 5404-5410. doi: 10.1016/j.vaccine.2005.04.047
-
Even-Or O, Samira S, Ellis R, Kedar E, Barenholz Y, 2013: Adjuvanted influenza vaccines[J]. Expert Rev Vaccines, 12, 1095-1108. doi: 10.1586/14760584.2013.825445
-
Feng Y, Mao H, Xu C, Jiang J, Chen Y, Yan J, Gao J, Li Z, Xia S, Lu Y, 2013: Origin and characteristics of internal genes affect infectivity of the novel avian-origin influenza A (H7N9) virus[J]. PLoS One, 8, e81136-. doi: 10.1371/journal.pone.0081136
-
Grant E, Wu C, Chan KF, Eckle S, Bharadwaj M, Zou QM, Kedzierska K, Chen W, 2013: Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses[J]. Immunol Cell Biol, 91, 184-194. doi: 10.1038/icb.2012.78
-
Grebe KM, Yewdell JW, Bennink JR, 2008: Heterosubtypic immunity to influenza A virus: where do we stand?[J]. Microbes Infect, 10, 1024-1029. doi: 10.1016/j.micinf.2008.07.002
-
Guan Y, Shortridge KF, Krauss S, Webster RG, 1999: Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?[J]. Proc Natl Acad Sci U S A, 96, 63-67.
-
Ichihashi T, Yoshida R, Sugimoto C, Takada A, Kajino K, 2011: Cross-protective peptide vaccine against influenza A viruses developed in HLA-A* 2402 human immunity model[J]. PLoS One, 6, e24626-. doi: 10.1371/journal.pone.0024626
-
Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, 2007: Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge[J]. Hum Vaccin, 3, 157-164. doi: 10.4161/hv.3.5.4175
-
Khanna M, Sharma S, Kumar B, Rajput R, 2014: Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development[J]. BioMed Res Int, , -.
-
Liniger M, Summerfield A, Ruggli N, 2012: MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens[J]. PLoS One, 7, e49952-. doi: 10.1371/journal.pone.0049952
-
Luo J, Zheng D, Zhang W, Fang F, Wang H, Sun Y, Ding Y, Xu C, Chen Q, Zhang H, 2012: Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein[J]. Virol J, 9, 286-. doi: 10.1186/1743-422X-9-286
-
Mastelic B, Garçon N, Del Giudice G, Golding H, Gruber M, Neels P, Fritzell B, 2013: Predictive markers of safety and immunogenicity of adjuvanted vaccines[J]. Biologicals, 41, 458-468. doi: 10.1016/j.biologicals.2013.08.006
-
Nelson DA, Marriott I, Bost KL, 2004: Expression of hemokinin 1 mRNA by murine dendritic cells[J]. J Neuroimmunol, 155, 94-102. doi: 10.1016/j.jneuroim.2004.06.005
-
Nguyen HH, van Ginkel FW, Vu HL, McGhee JR, Mestecky J, 2001: Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes[J]. J Infect Dis, 183, 368-376. doi: 10.1086/jid.2001.183.issue-3
-
Okamatsu M, Sakoda Y, Kishida N, Isoda N, Kida H, 2008: Antigenic structure of the hemagglutinin of H9N2 influenza viruses[J]. Arch Virol, 153, 2189-2195. doi: 10.1007/s00705-008-0243-2
-
Palese P, García-Sastre A, 2002: Influenza vaccines: present and future[J]. J Clin Invest, 110, 9-13. doi: 10.1172/JCI0215999
-
Prabakaran M, Madhan S, Prabhu N, Qiang J, Kwang J, 2010: Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection[J]. J Virol, 84, 3201-3209. doi: 10.1128/JVI.02175-09
-
Qiu M, Fang F, Chen Y, Wang H, Chen Q, Chang H, Wang F, Wang H, Zhang R, Chen Z, 2006: Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin-or neuraminidase-expressing DNA in BALB/c mice[J]. Biochem Biophys Res Commun, 343, 24-31.
-
Rao SS, Kong WP, Wei CJ, Van Hoeven, Gorres JP, Nason M, Andersen H, Tumpey TM, Nabel GJ, 2010: Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein genebased vaccination against H5N1 influenza in mouse and ferret[J]. PLoS One, 5, e9812-. doi: 10.1371/journal.pone.0009812
-
Shahsavandi S, Salmanian A-H, Ghorashi SA, Masoudi S, Ebrahimi MM, 2012: Evolutionary characterization of hemagglutinin genee of H9N2 influenza viruses isolated from Asia[J]. Res Vet Sci, 93, 234-249. doi: 10.1016/j.rvsc.2011.07.033
-
Shaw ML, Palese P. 2013. Fields Virology. 5th ed. Philadelphia: Lippincott-Raven. pp. 1151-1186.
-
Staneková Z, Vareckova E, 2010: Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development[J]. Virol J, 7, 351-. doi: 10.1186/1743-422X-7-351
-
Sun Y, Liu J, Yang M, Gao F, Zhou J, Kitamura Y, Gao B, Tien P, Shu Y, 2010: Iwamoto, A. Identification and structural definition of H5-specific CTL epitopes restricted by HLA-A* 0201 derived from the H5N1 subtype of influenza A viruses[J]. J Gen Virol, 91, 919-930. doi: 10.1099/vir.0.016766-0
-
Tumpey TM, Renshaw M, Clements JD, Katz JM, 2001: Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection[J]. J Virol, 75, 5141-5150. doi: 10.1128/JVI.75.11.5141-5150.2001
-
Wan Z, Ye J, Xu L, Shao H, Jin W, Qian K, Wan H, Qin A, 2014: Antigenic mapping of the hemagglutinin of an H9N2 avian influenza virus reveals novel critical amino acid positions in antigenic sites[J]. J Virol, 88, 3898-3901. doi: 10.1128/JVI.03440-13
-
Wang M, Larsen M V, Nielsen M, Harndahl M, Justesen S, Dziegiel MH, Buus S, Tang ST, Lund O, Claesson MH, 2010: HLA Class Ⅰ binding 9 mer peptides from influenza A virus induce CD4+ T cell responses[J]. PLoS One, 5, e10533-. doi: 10.1371/journal.pone.0010533
-
Watanabe T, Watanabe S, Kim JH, Hatta M, Kawaoka Y, 2008: Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants[J]. J Virol, 82, 2486-2492. doi: 10.1128/JVI.01899-07
-
Wiederstein M, Sippl MJ, 2007: ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins[J]. Nucleic Acids Res, 35, W407-W410. doi: 10.1093/nar/gkm290
-
Zhang Y, Berger A, Milne CD, Paige CJ, 2006: Tachykinins in the immune system[J]. Curr Drug Targets, 7, 1011-1020. doi: 10.2174/138945006778019363
-
Zhang Y, Lu L, Furlonger C, Wu GE, Paige CJ, 2000: Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis[J]. Nat Immunol, 1, 392-397. doi: 10.1038/80826
-
Zhang Y, Paige CJ, 2003: T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis[J]. Blood, 102, 2165-2172. doi: 10.1182/blood-2002-11-3572
-
Zheng L, Wang F, Yang Z, Chen J, Chang H, Chen ZA, 2009: Single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice[J]. BMC Infect Dis, 9, 17-. doi: 10.1186/1471-2334-9-17